Balaxi Pharmaceuticals Ltd

Fri 4/09/2026,15:52:45 | NSE : BALAXI

₹25.37-0.43 (-1.67%)

Data is delayed. Analysis is best done in real-time! Open a FREE Sharekhan Demat A/c in 15 mins* and continue your analysis with real-time data.

Market Data

Essential tool: analyze, trade, manage, decide.

Open

₹ 26.60

Previous Close

₹ 25.80

Volume

50780

Mkt Cap ( ₹ Cr)

₹ 140.06

High

₹ 26.60

Low

₹ 24.93

52 Week High

₹ 47.87

52 Week Low

₹ 15.20

Book Value Per Share

₹ 45.35

Dividend Yield

₹ 0.00

Face Value

₹₹2.00

What's Your Call?

Collective community sentiment on Balaxi Pharmaceuticals Ltd

Your Vote -

Buy

33.33%

Hold

50.00%

Sell

16.67%

33.33%

30 users have voted

Market Depth

How many stocks are available to buy or sell and at what prices.

Buy Order Quantity

100%

Sell Order Quantity

0%

Bid Price

Qty

25.37

2

0.00

0

0.00

0

0.00

0

0.00

0

Bid Total

2

Bid Price

Qty

0.00

0

0.00

0

0.00

0

0.00

0

0.00

0

Bid Total

0

Option Chain

Analyzes market sentiment, predicts Balaxi Pharmaceuticals Ltd' movement.

NO_RECORD_FOUND

News

Media spotlight triggers stock stock attention, sentiment.

  • Balaxi Pharma. - General Updates

    31 Aug 2026, 12:59PM Balaxi Pharmaceuticals Limited has informed the Exchange about the receipt of WHO-GMP Certification for Company's Pharmaceutical Formulation Manufactu
  • Balaxi Pharma. - Change in Director(s)

    24 Aug 2026, 11:37PM BALAXI PHARMACEUTICALS LIMITED has informed the Exchange regarding Change in Director(s) of the company.
  • Balaxi Pharma. - Shareholders meeting

    24 Aug 2026, 11:15PM BALAXI PHARMACEUTICALS LIMITED has submitted the Exchange a copy Srutinizers Report of Annual General Meeting held on 24th August, 2026. Further, the
  • Balaxi Pharma. - Shareholders meeting

    24 Aug 2026, 10:56PM BALAXI PHARMACEUTICALS LIMITED has informed the Exchange regarding Proceedings of the 83rd Annual General Meeting held on 24th August, 2026
  • Balaxi Pharma. posts Q1 net loss of Rs 1.25 cr

    19 Aug 2026, 8:20PM The company reported standalone net loss during the quarter stood at Rs 1.25 crore compared to net profit of Rs 0.19 crore in the previous year quarte
  • Balaxi Pharma. - Copy of Newspaper Publication

    14 Aug 2026, 12:45PM BALAXI PHARMACEUTICALS LIMITED has informed the Exchange about Copy of Newspaper Publication.
  • Balaxi Pharma. - Copy of Newspaper Publication

    11 Aug 2026, 11:14AM BALAXI PHARMACEUTICALS LIMITED has informed the Exchange about Copy of Newspaper Publication.
  • Balaxi Pharma. - Corrigendum

    10 Aug 2026, 12:20PM BALAXI PHARMACEUTICALS LIMITED has informed the Exchange regarding Corrigendum to Notice of the 83rd Annual General Meeting.
  • Balaxi Pharma. - Updates

    7 Aug 2026, 10:06PM BALAXI PHARMACEUTICALS LIMITED has informed the Exchange regarding '''RTA Report for Re-lodgement of Transfer Requests of Physical Shares for the peri
  • Balaxi Pharma. - Investor Presentation

    6 Aug 2026, 4:17PM BALAXI PHARMACEUTICALS LIMITED has informed the Exchange about Investor Presentation
  • Balaxi Pharma. - Copy of Newspaper Publication

    6 Aug 2026, 1:17PM Balaxi Pharmaceuticals Limited has informed the Exchange about Copy of Newspaper Publication.
  • Balaxi Pharma. - Updates

    5 Aug 2026, 2:01PM Balaxi Pharmaceuticals Limited has informed the Exchange regarding Progress of the Company's First Pharmaceutical Formulation Plant at Jadcherla, Hyd
  • Balaxi Pharma. - Outcome of Board Meeting

    5 Aug 2026, 1:55PM Balaxi Pharmaceuticals Limited has informed the Exchange regarding Outcome of Board Meeting held on 05th August, 2026.
  • Balaxi Pharma. - Outcome of Board Meeting

    5 Aug 2026, 1:51PM Balaxi Pharmaceuticals Limited has submitted to the Exchange, the financial results for the quarter ended 30th June, 2026.
  • Balaxi Pharma. - Copy of Newspaper Publication

    1 Aug 2026, 2:06PM Balaxi Pharmaceuticals Limited has informed the Exchange about Copy of Newspaper Publication post-dispatch of the 83rd AGM Notice and Annual Report (F
  • Balaxi Pharma. - Updates

    31 Jul 2026, 1:20PM BALAXI PHARMACEUTICALS LIMITED has informed the Exchange regarding 'Balaxi Pharmaceuticals Limited has informed the Exchange regarding 'BRSR for FY 2
  • Balaxi Pharma. - Shareholders meeting

    31 Jul 2026, 1:00PM Balaxi Pharmaceuticals Limited has informed the Exchange regarding Notice of 83rd Annual General Meeting to be held on 24th August, 2026.
  • Balaxi Pharma. has submitted to BSE the Shareholding Pattern for the Period Ended June 30, 2026

    21 Jul 2026, 8:00PM As of June 2026, 65.99% is owned by Indian Promoters and 34.01% by Public. <p align=justify> Top four Promoters holding highest number of shares of Ba
  • Balaxi Pharma. - Copy of Newspaper Publication

    20 Jul 2026, 4:27PM BALAXI PHARMACEUTICALS LIMITED has informed the Exchange about Copy of Newspaper Publication
  • Balaxi Pharma. - Reply to Clarification- Financial results

    14 Jul 2026, 11:45AM The Exchange had sought clarification from BALAXI PHARMACEUTICALS LIMITED for the quarter ended 31-Mar-2026 with respect to Regulation 33 of the SEBI
  • Balaxi Pharma. - Updates

    9 Jul 2026, 5:12PM 'BALAXI PHARMACEUTICALS LIMITED' has informed the Exchange regarding '''RTA Report for Re-lodgement of Transfer Requests of Physical Shares for the pe
  • Balaxi Pharma. - Certificate under SEBI (Depositories and Participants) Regulations, 2018

    9 Jul 2026, 3:20PM BALAXI PHARMACEUTICALS LIMITED has informed the Exchange about Certificate under SEBI (Depositories and Participants) Regulations, 2018
  • Balaxi Pharma. - Trading Window

    26 Jun 2026, 1:12PM BALAXI PHARMACEUTICALS LIMITED has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regula
  • Balaxi Pharma. - Clarification - Financial Results

    24 Jun 2026, 9:01AM The Exchange has sought clarification from BALAXI PHARMACEUTICALS LIMITED for the quarter ended 31-Mar-2026 with respect to Regulation 33 of the SEBI
  • Balaxi Pharma. - Copy of Newspaper Publication

    16 Jun 2026, 2:02PM BALAXI PHARMACEUTICALS LIMITED has informed the Exchange about Copy of Newspaper Publication

Key fundamentals

Evaluate the intrinsic value of Balaxi Pharmaceuticals Ltd stock 

Name March-26 March-25 March-24 March-23 March-22
Assets 166.4364 158.2324 135.5029 102.8575 59.843
Liabilities 166.4364 158.2324 135.5029 102.8575 59.843
Equity 11.0415 11.0415 10.8977 10.1813 10
Gross Profit 0.764 2.428 5.2363 16.8208 17.262
Net Profit 5.1469 3.6013 3.6503 16.2221 14.6674
Cash From Operating Activities 43.8727 -7.6023 -1.8307 -7.0662 8.8866
NPM(%) 6.36 5.9 5.2 15 14.48
Revenue 80.8511 60.9882 70.196 108.1376 101.2918
Expenses 80.0871 58.5602 64.9597 91.3168 84.0298
ROE(%) 2.05 1.43 1.45 6.47 5.85

Shareholding Pattern

Corporate Action

XD-Date Dividend-Amount Dividend-% Dividend Yield(%GE) Price on that day

Peers

Other companies within the same industry or sector that are comparable to Balaxi Pharmaceuticals Ltd

Company Price Price (% change) pe(x) EV/EBITDA(x) ROE(%) ROCE(%)
Elgi Rubber Company Ltd 58.69 -0.66 0.00 0.00 -4799.96 0.00
Gayatri Rubbers and Chemicals Ltd 575.00 0.85 59.03 0.00 97.38 0.00
Apar Industries Ltd 17421.00 -1.60 61.74 0.00 2333.12 0.34
Pix Transmissions Ltd 1791.70 -0.43 18.53 0.00 784.48 0.50

Company Info

The Anandam Rubber Co. Ltd. Incorporated in the year 1942 as a Public Ltd Company under The Travancore Companies Act 1114, having Registered office at Kottayam Taluk, Travancore. The Company incorporated as a plantation Company and acquired several Rubber and Tea plantations across South India namely, Anandam, Ennooramvayil, Ancheril, Elambramala and Pookkulam Estate. The main object clause of the Company also provides to carry on the business as an investment Company.In the year 1944, the Company made public issue (IPO) of equity shares and got listed at Madras Stock Exchange Ltd., Chennai. From the beginning itself our Company maintains good compliance record at MSE.The Company gave excellent returns to its members both by way of good dividend and bonus shares.The Company sold its last estate in the year 1989 and temporally existed from plantation business. From 1989 onwards the Company functions as an investment Company generating distributable profit as defined under section 205 of Companies Act 1956 and giving continuous dividend for last 15 years.In the year 2010, the present promoters took over the Company after complying with all provision of SEBI Takeover Code and continue to function as an Investment Company.The present board of the Company consists of persons having good experience in the fields of investment, Finance, Agriculture, Medicine.The Seven decade old Company have not undergone any reorganization, reconstruction, Amalgamation or name change during its long journey. 2017 -Company name has changed to Balaxi Ventures Ltd. from The Anandam Rubber Company Ltd.. 2020 -Company name has changed to Balaxi Pharmaceuticals Ltd. from Balaxi Ventures Ltd.. 2024 -The Company has splits its face value from Rs. 10/- to Rs. 2/-.

The Anandam Rubber Co. Ltd. Incorporated in the year 1942 as a Public Ltd Company under The Travancore Companies Act 1114, having Registered office at Kottayam Taluk, Travancore. The Company incorporated as a plantation Company and acquired several Rubber and Tea plantations across South India namely, Anandam, Ennooramvayil, Ancheril, Elambramala and Pookkulam Estate. The main object clause of the Company also provides to carry on the business as an investment Company.In the year 1944, the Company made public issue (IPO) of equity shares and got listed at Madras Stock Exchange Ltd., Chennai. From the beginning itself our Company maintains good compliance record at MSE.The Company gave excellent returns to its members both by way of good dividend and bonus shares.The Company sold its last estate in the year 1989 and temporally existed from plantation business. From 1989 onwards the Company functions as an investment Company generating distributable profit as defined under section 205 of Companies Act 1956 and giving continuous dividend for last 15 years.In the year 2010, the present promoters took over the Company after complying with all provision of SEBI Takeover Code and continue to function as an Investment Company.The present board of the Company consists of persons having good experience in the fields of investment, Finance, Agriculture, Medicine.The Seven decade old Company have not undergone any reorganization, reconstruction, Amalgamation or name change during its long journey. 2017 -Company name has changed to Balaxi Ventures Ltd. from The Anandam Rubber Company Ltd.. 2020 -Company name has changed to Balaxi Pharmaceuticals Ltd. from Balaxi Ventures Ltd.. 2024 -The Company has splits its face value from Rs. 10/- to Rs. 2/-.

Parent Organisation

Balaxi Pharmaceuticals Ltd.

Founded

28/09/1942

Managing Director

Mr.Ashish Maheshwari

NSE Symbol

BALAXIEQ

FAQ